QIAGEN to Acquire Parse Biosciences

Parse Biosciences Acquires Biomage

January 16, 2024

Software

Parse Biosciences has acquired data analysis software company Biomage, integrating Biomage's cloud-based single-cell RNA sequencing analysis platform into Parse's product portfolio. The deal will give Parse customers access to faster, intuitive single-cell data analysis (Biomage's Cellenics/Cellscope), pairing Parse's Evercode combinatorial barcoding technology with Biomage's analysis tools to reduce analysis time and expand capabilities.

Paragon Group Acquires Parseq Limited

February 13, 2026

Professional Services

Paragon Group has acquired Parseq Limited, a UK-based specialist in document, finance, and payment process automation, to strengthen its business process services capabilities. The deal (which includes 354 employees globally) is intended to expand Paragon's UK footprint, accelerate innovation by integrating Parseq's robotic process automation and machine learning capabilities, and secure intellectual property for financial services clients.

QIAGEN Acquires Verogen

January 9, 2023

Biotechnology

QIAGEN completed the acquisition of Verogen for $150 million in cash, bringing Verogen’s NGS-based human identification and forensic genomics products and the GEDmatch database into QIAGEN’s forensics portfolio. The deal gives QIAGEN exclusive distribution rights for the MiSeq FGx forensic sequencer version and is intended to expand QIAGEN’s capabilities and commercial footprint in the fast-growing Human ID/forensics market.

CellCarta Acquires Biogazelle

December 14, 2021

Biotechnology

CellCarta has acquired Biogazelle, a Ghent-based leader in digital PCR (dPCR), qPCR and RNASeq assay development, to strengthen and expand its genomic capabilities. The acquisition creates a Center of Excellence for complex genomic biomarker assay development within CellCarta and broadens its service offering for pharmaceutical and biotech clients across discovery and clinical stages.

Illumina Acquires SomaLogic from Standard BioTools to Expand Proteomics and Multiomics

January 30, 2026

Healthcare Services

Illumina, Inc. completed the acquisition of SomaLogic to expand its data-driven proteomics and multiomics capabilities. The deal is valued at $350 million in upfront cash paid at closing, plus up to $75 million in near-term performance-based milestones and performance-based royalties, with SomaLogic products and services expected to be supported during integration into Illumina’s roadmap.

QIAGEN Acquires Genoox

May 12, 2025

Biotechnology

QIAGEN has signed a definitive agreement to acquire Genoox, the developer of the AI-powered Franklin clinical genomics platform, for $70 million in cash plus up to $10 million in milestone payments. The acquisition adds Genoox's cloud-based AI interpretation capabilities to QIAGEN Digital Insights, expanding QIAGEN's clinical genomics and diagnostic software offerings for labs and healthcare organizations worldwide.